(lp0
S'Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare ... PR Newswire  - Mar 27, 2017 SAN DIEGO, March 27, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc.  a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that Amit Munshi, the&nbsp;...'
p1
aS"Today's Research Reports on Biotech Stocks to Watch: Arena Pharmaceuticals and ... Yahoo Finance - 18 hours ago Arena Pharmaceuticals' investors breathe a sigh of relief with the company now experiencing positive results with regard to its share value."
p2
aS'Arena Pharmaceuticals Appoints Dr. Preston Klassen, MD, MHS as Executive Vice ... PR Newswire  - Mar 20, 2017 SAN DIEGO, March 20, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced the appointment of Dr.'
p3
aS'Company Update : Arena Pharmaceuticals, Inc. Announces 4Q and ... Smarter Analyst - Mar 14, 2017 Arena Pharmaceuticals, Inc.  reported financial results for the fourth quarter and full-year ended December 31, 2016 and provided a corporate update.Arena Pharmaceuticals  Posts Q4 Earnings, Revenues Up - Yahoo FinanceArena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and ... - PR Newswire '
p4
aS"Arena Pharmaceuticals, Inc.  hit its 52 Week high of $2.16 on Jun 9, 2016 The Newburgh Press - 18 hours ago Considering the performance, Arena Pharmaceuticals, Inc. 's shares have the potential to reach a high EPS of -0.02 per share, and a low EPS of -0.1 per share in the current quarter.Latest Stocks: Arena Pharmaceuticals, Inc.  Receives Consensus Rating of ... - Petro Global News 24Arena Pharmaceuticals, Inc. performed Very Well with a change of 0.69% in the ... - Free Observer"
p5
aS'Looking at the Levels for Arena Pharmaceuticals, Inc.  The Standard - 14 hours ago Looking at shares of Arena Pharmaceuticals, Inc. , the company has an EV  of 431506. Enterprise Value is a measure of the total value of a specific company.'
p6
aS"Arena Pharmaceuticals  Q4 Earnings: What to Expect? Yahoo Finance - Feb 27, 2017 Arena Pharmaceuticals, Inc. ARNA is expected to report fourth-quarter 2016 results next month. The company delivered a positive earnings surprise of 28.57% last quarter.What's On Focus As Arena Pharmaceuticals, Inc.  Reports Q4? - StockNewsUnionArena Pharmaceuticals, Inc.  has 1 year Price Target of $4.5 - The Newburgh Press"
p7
aS'Inspecting more closely technicals of Arena Pharmaceuticals, Inc.  USA Commerce Daily - 16 hours ago With all other things going on, Arena Pharmaceuticals, Inc.  has been on a run - rising 1.36 percent in just three months.'
p8
aS'Arena Pharmaceuticals to Present at the 27th Annual Oppenheimer Healthcare ... PR Newswire  - Mar 8, 2017 SAN DIEGO, March 8, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing novel, small molecule drugs across multiple therapeutic areas, today announced that Amit Munshi, the&nbsp;...'
p9
aS'Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter ... GlobeNewswire  - Mar 6, 2017 SAN DIEGO, March 06, 2017  -- Arena Pharmaceuticals, Inc. , today announced that the Company will provide a corporate update and release its fourth quarter and full-year 2016 financial results on Tuesday, March 14,&nbsp;...Today Arena Pharmaceuticals, Inc.  Receives Consensus Rating of Hold ... - DailyQuintAnalyst Earnings Report: Arena Pharmaceuticals  - News Oracle'
p10
a.